Dose-Limiting Bone Marrow Toxicities After Peptide Receptor Radionuclide Therapy Are More Prevalent in Women Than in Men

Research output: Contribution to journalArticleAcademicpeer-review

1 Citation (Web of Science)

Fingerprint

Dive into the research topics of 'Dose-Limiting Bone Marrow Toxicities After Peptide Receptor Radionuclide Therapy Are More Prevalent in Women Than in Men'. Together they form a unique fingerprint.

Medicine and Dentistry

Nursing and Health Professions

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience